(10-267) Efficacy and Safety of Low-Dose Anti-Thymocyte Globulin Compared to Moderate-Dose Anti-Thymocyte Globulin for Induction Therapy in Kidney Transplantation
Wednesday, December 10, 2025
11:00 AM - 12:00 PM
Location: Bayside A, Level 1
Residency Program: The University of Kansas Health System Residency Program Type: PGY1 (Pharmacy) Residency Program Location: Kansas
Co-Author(s): Rexhian Brisku, Jessica Stone, Jessica Werth, Bradley Berak